COURTNEY WYATT: Open Payments
NPI 1568246395 · NORTH CHESTERFIELD, VA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$244 in 12 payments from 7 companies in 2025. Trend: 2023 $0 · 2024 $14 · 2025 $244
Food & beverage: $244
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 3 | $53 |
| Lilly USA, LLC | 3 | $53 |
| Vanda Pharmaceuticals Inc. | 1 | $39 |
| Novo Nordisk Inc | 2 | $39 |
| Actelion Pharmaceuticals US, Inc. | 1 | $25 |
| Otsuka America Pharmaceutical, Inc. | 1 | $21 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 1 | $14 |
Products named: MOUNJARO, FANAPT, UBRELVY, UPTRAVI, REXULTI, QULIPTA, Wegovy, XIFAXAN.
Industry payments across VA — which companies pay providers there.
